Biovie (BIVI) Cash & Equivalents (2013 - 2026)
Biovie (BIVI) reported Cash & Equivalents of $8.98 million for fiscal Q4 2026 (quarter ended Jun 30, 2026), down 48.8% from $17.54 million a year earlier and down 31.5% from the prior quarter.
Powered by 
Analysis
Biovie (BIVI) Cash & Equivalents (2013 - 2026) Analysis & Trends
Dating back to fiscal Q4 2013, Biovie's Cash & Equivalents record includes 52 quarters.
- Cash & Equivalents has a five-year compound annual growth rate of 14.8% (FY2021 to FY2026).
- By fiscal year, Cash & Equivalents came in at $17.54 million in FY2025 (-26.4%), $23.84 million in FY2024 (+22.5%), $19.46 million in FY2023 (+4.4%) and $18.64 million in FY2022 (+313.2%).
- The fiscal Q4 2026 figure ranks as the lowest quarterly Cash & Equivalents since fiscal Q4 2021.
- Year over year, Cash & Equivalents has now declined in each of the last three quarters, with an average decline of 14.8% over the last eight quarters.
- The high point for year-over-year Cash & Equivalents in five years was fiscal Q4 2022 (growth of 313.2%); the low point was fiscal Q2 2024 (a decline of 55.8%).
- Per Business Quant data, the three fiscal quarters before Q4 2026 came in at $13.1 million (Q3 2026), $20.54 million (Q2 2026) and $24.98 million (Q1 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 4.89 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Biovie | 11.01 Mn | 11.01 Mn | - | 8.98 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 8.98 Mn |
| Mar 31, 2026 | 13.10 Mn |
| Dec 31, 2025 | 20.54 Mn |
| Sep 30, 2025 | 24.98 Mn |
| Jun 30, 2025 | 17.54 Mn |
| Mar 31, 2025 | 23.15 Mn |
| Dec 31, 2024 | 24.41 Mn |
| Sep 30, 2024 | 20.02 Mn |
| Jun 30, 2024 | 23.84 Mn |
| Mar 31, 2024 | 30.35 Mn |
| Dec 31, 2023 | 20.23 Mn |
| Sep 30, 2023 | 21.21 Mn |
| Jun 30, 2023 | 19.46 Mn |
| Mar 31, 2023 | 31.28 Mn |
| Dec 31, 2022 | 45.75 Mn |
| Sep 30, 2022 | 21.23 Mn |
| Jun 30, 2022 | 18.64 Mn |
| Mar 31, 2022 | 24.51 Mn |
| Dec 31, 2021 | 30.39 Mn |
| Sep 30, 2021 | 20.49 Mn |
API Access
Biovie Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=BIVI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "BIVI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=BIVI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();